{"id":1190,"date":"2021-04-12T10:19:06","date_gmt":"2021-04-12T13:19:06","guid":{"rendered":"http:\/\/www.diariodepe.com.br\/xinhua\/?p=1190"},"modified":"2021-04-12T10:19:08","modified_gmt":"2021-04-12T13:19:08","slug":"china-aprova-nova-vacina-de-covid-19-para-testes-clinicos","status":"publish","type":"post","link":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/","title":{"rendered":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos"},"content":{"rendered":"\n<p>Beijing, 11 abr (Xinhua) &#8212; Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.<\/p>\n\n\n\n<p>A nova vacina recombinante contra COVID-19, desenvolvida pelo National Vaccine &amp; Serum Institute, um centro de P&amp;D da subsidi\u00e1ria de bioci\u00eancias da Sinopharm, o China National Biotec Group (CNBG), obteve aprova\u00e7\u00e3o da Administra\u00e7\u00e3o Nacional de Produtos M\u00e9dicos na sexta-feira, disse a CNBG em sua conta oficial da Weibo no s\u00e1bado.<\/p>\n\n\n\n<p>A vacina \u00e9 baseada nas caracter\u00edsticas estruturais do dom\u00ednio receptor de liga\u00e7\u00e3o (RBD) na prote\u00edna do pico do v\u00edrus (S-protein). Ela usa a engenharia gen\u00e9tica para cultivar c\u00f3pias inofensivas da S-protein do v\u00edrus para induzir anticorpos neutralizantes.<\/p>\n\n\n\n<p>A empresa disse que a tecnologia de vacinas recombinantes \u00e9 madura e adequada para produ\u00e7\u00e3o em larga escala. A produ\u00e7\u00e3o n\u00e3o requer instala\u00e7\u00f5es com altos n\u00edveis de biosseguran\u00e7a, uma vez que o processo n\u00e3o envolve v\u00edrus vivos.<\/p>\n\n\n\n<p>A vacina recombinante \u00e9 a terceira vacina contra COVID-19 da empresa. Em dezembro passado, uma vacina inativada desenvolvida pelo Beijing Biological Products Institute Co., Ltd. sob a CNBG tornou-se a primeira vacina chinesa de COVID-19 a ter autoriza\u00e7\u00e3o condicional de comercializa\u00e7\u00e3o.<\/p>\n\n\n\n<p>Em fevereiro, outra vacina inativada do Instituto Wuhan de Produtos Biol\u00f3gicos, uma afiliada da CNBG, foi autorizada a entrar no mercado de forma condicional.<\/p>\n\n\n\n<p>Mais de 161,12 milh\u00f5es de doses de vacinas contra COVID-19 haviam sido administradas em toda a China at\u00e9 sexta-feira, disse a Comiss\u00e3o Nacional de Sa\u00fade no s\u00e1bado.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beijing, 11 abr (Xinhua) &#8212; Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos. A nova vacina recombinante contra COVID-19, desenvolvida pelo National Vaccine &amp; Serum Institute, um centro de P&amp;D da subsidi\u00e1ria&#8230;<\/p>\n","protected":false},"author":3,"featured_media":1191,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-china"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco<\/title>\n<meta name=\"description\" content=\"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco\" \/>\n<meta property=\"og:description\" content=\"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/\" \/>\n<meta property=\"og:site_name\" content=\"Xinhua - Diario de Pernambuco\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-12T13:19:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-12T13:19:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marcelo Oliveira de A. Maranhao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marcelo Oliveira de A. Maranhao\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/\"},\"author\":{\"name\":\"Marcelo Oliveira de A. Maranhao\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#\\\/schema\\\/person\\\/0943d6fd02bdc7b49c8f495e8787a2cb\"},\"headline\":\"China aprova nova vacina de COVID-19 para testes cl\u00ednicos\",\"datePublished\":\"2021-04-12T13:19:06+00:00\",\"dateModified\":\"2021-04-12T13:19:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/\"},\"wordCount\":274,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/04\\\/139873074_16181372053681n.jpg\",\"articleSection\":[\"China\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/\",\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/\",\"name\":\"China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/04\\\/139873074_16181372053681n.jpg\",\"datePublished\":\"2021-04-12T13:19:06+00:00\",\"dateModified\":\"2021-04-12T13:19:08+00:00\",\"description\":\"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/04\\\/139873074_16181372053681n.jpg\",\"contentUrl\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/04\\\/139873074_16181372053681n.jpg\",\"width\":900,\"height\":600,\"caption\":\"Pessoas recebem a vacina contra COVID-19 em um local de vacina\u00e7\u00e3o no distrito de Gulou em Nanjing, Prov\u00edncia de Jiangsu, no leste da China, em 9 de abril de 2021.(Xinhua\\\/Li Bo)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/2021\\\/04\\\/12\\\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China aprova nova vacina de COVID-19 para testes cl\u00ednicos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#website\",\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/\",\"name\":\"Xinhua - Diario de Pernambuco\",\"description\":\"A maior ag\u00eancia de not\u00edcias da China e um dos principais canais para conhecer o pa\u00eds\",\"publisher\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#organization\",\"name\":\"Xinhua - Diario de Pernambuco\",\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2020\\\/10\\\/cropped-logo-transparente-2.png\",\"contentUrl\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2020\\\/10\\\/cropped-logo-transparente-2.png\",\"width\":512,\"height\":164,\"caption\":\"Xinhua - Diario de Pernambuco\"},\"image\":{\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/#\\\/schema\\\/person\\\/0943d6fd02bdc7b49c8f495e8787a2cb\",\"name\":\"Marcelo Oliveira de A. Maranhao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g\",\"caption\":\"Marcelo Oliveira de A. Maranhao\"},\"url\":\"https:\\\/\\\/diariodepe.com.br\\\/xinhua\\\/author\\\/marcelo-maranhao\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco","description":"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/","og_locale":"pt_BR","og_type":"article","og_title":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco","og_description":"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.","og_url":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/","og_site_name":"Xinhua - Diario de Pernambuco","article_published_time":"2021-04-12T13:19:06+00:00","article_modified_time":"2021-04-12T13:19:08+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg","type":"image\/jpeg"}],"author":"Marcelo Oliveira de A. Maranhao","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Marcelo Oliveira de A. Maranhao","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#article","isPartOf":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/"},"author":{"name":"Marcelo Oliveira de A. Maranhao","@id":"https:\/\/diariodepe.com.br\/xinhua\/#\/schema\/person\/0943d6fd02bdc7b49c8f495e8787a2cb"},"headline":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos","datePublished":"2021-04-12T13:19:06+00:00","dateModified":"2021-04-12T13:19:08+00:00","mainEntityOfPage":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/"},"wordCount":274,"commentCount":0,"publisher":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/#organization"},"image":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#primaryimage"},"thumbnailUrl":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg","articleSection":["China"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/","url":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/","name":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos - Xinhua - Diario de Pernambuco","isPartOf":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/#website"},"primaryImageOfPage":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#primaryimage"},"image":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#primaryimage"},"thumbnailUrl":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg","datePublished":"2021-04-12T13:19:06+00:00","dateModified":"2021-04-12T13:19:08+00:00","description":"Uma nova vacina contra COVID-19 desenvolvida pela Sinopharm da China foi recentemente aprovada para testes cl\u00ednicos.","breadcrumb":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#primaryimage","url":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg","contentUrl":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2021\/04\/139873074_16181372053681n.jpg","width":900,"height":600,"caption":"Pessoas recebem a vacina contra COVID-19 em um local de vacina\u00e7\u00e3o no distrito de Gulou em Nanjing, Prov\u00edncia de Jiangsu, no leste da China, em 9 de abril de 2021.(Xinhua\/Li Bo)"},{"@type":"BreadcrumbList","@id":"https:\/\/diariodepe.com.br\/xinhua\/2021\/04\/12\/china-aprova-nova-vacina-de-covid-19-para-testes-clinicos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/diariodepe.com.br\/xinhua\/"},{"@type":"ListItem","position":2,"name":"China aprova nova vacina de COVID-19 para testes cl\u00ednicos"}]},{"@type":"WebSite","@id":"https:\/\/diariodepe.com.br\/xinhua\/#website","url":"https:\/\/diariodepe.com.br\/xinhua\/","name":"Xinhua - Diario de Pernambuco","description":"A maior ag\u00eancia de not\u00edcias da China e um dos principais canais para conhecer o pa\u00eds","publisher":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diariodepe.com.br\/xinhua\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/diariodepe.com.br\/xinhua\/#organization","name":"Xinhua - Diario de Pernambuco","url":"https:\/\/diariodepe.com.br\/xinhua\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/diariodepe.com.br\/xinhua\/#\/schema\/logo\/image\/","url":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2020\/10\/cropped-logo-transparente-2.png","contentUrl":"https:\/\/diariodepe.com.br\/xinhua\/wp-content\/uploads\/sites\/3\/2020\/10\/cropped-logo-transparente-2.png","width":512,"height":164,"caption":"Xinhua - Diario de Pernambuco"},"image":{"@id":"https:\/\/diariodepe.com.br\/xinhua\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/diariodepe.com.br\/xinhua\/#\/schema\/person\/0943d6fd02bdc7b49c8f495e8787a2cb","name":"Marcelo Oliveira de A. Maranhao","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f562caee940d39879c20e90eea3e4b21860c7d4c96684c23141c554824f0059c?s=96&d=mm&r=g","caption":"Marcelo Oliveira de A. Maranhao"},"url":"https:\/\/diariodepe.com.br\/xinhua\/author\/marcelo-maranhao\/"}]}},"cc_featured_image_caption":{"caption_text":"","source_text":"","source_url":""},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/posts\/1190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/comments?post=1190"}],"version-history":[{"count":1,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/posts\/1190\/revisions"}],"predecessor-version":[{"id":1192,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/posts\/1190\/revisions\/1192"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/media\/1191"}],"wp:attachment":[{"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/media?parent=1190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/categories?post=1190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diariodepe.com.br\/xinhua\/wp-json\/wp\/v2\/tags?post=1190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}